Back
Windtree Therapeutics Stock Price Chart
Economy going through a "period of transition" - Your portfolio doesn't have to
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
19
WINT
Windtree Therapeutics
Last Price:
$1.93
Seasonality Move:
-6.48%
7 Day Trial
ALL ACCESS PASS
$
7
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WINT is experiencing selling pressure, which indicates risk of future bearish movement.
Windtree Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.99 | Sell |
| 20-day SMA: | 3.46 | Sell |
| 50-day SMA: | 7.62 | Sell |
| 200-day SMA: | 128.47 | Sell |
| 8-day EMA: | 2.21 | Sell |
| 20-day EMA: | 3.51 | Sell |
| 50-day EMA: | 10.64 | Sell |
| 200-day EMA: | 259.82 | Sell |
Windtree Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.78 | Sell |
| Relative Strength Index (14 RSI): | 22.01 | Sell |
| Chaikin Money Flow: | -27818 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.03 - 6.35) | Sell |
| Bollinger Bands (100): | (4.97 - 30.69) | Sell |
Windtree Therapeutics Technical Analysis
| Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Windtree Therapeutics Stock
Is Windtree Therapeutics Stock a Buy?
-
Windtree Therapeutics share price is 1.92 while WINT 8-day simple moving average is 1.99, which is a Sell signal.
-
The stock price of WINT is 1.92 while Windtree Therapeutics 20-day SMA is 3.46, which makes it a Sell.
-
Windtree Therapeutics 50-day simple moving average is 7.62 while WINT share price is 1.92, making it a Sell technically.
-
WINT stock price is 1.92 and Windtree Therapeutics 200-day simple moving average is 128.47, creating a Sell signal.
WINT Technical Analysis vs Fundamental Analysis
Sell
19
Windtree Therapeutics (WINT)
is a Sell
Is Windtree Therapeutics a Buy or a Sell?
-
Windtree Therapeutics stock is rated a SellThe current Windtree Therapeutics [WINT] share price is $1.92. The Score for WINT is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Windtree Therapeutics Stock Info
Market Cap:
1.4M
Price in USD:
1.92
Share Volume:
37.1K
Windtree Therapeutics 52-Week Range
52-Week High:
737.44
52-Week Low:
1.78
Sell
19
Windtree Therapeutics (WINT)
is a Sell
Windtree Therapeutics Share Price Forecast
-
What is the Windtree Therapeutics stock price today?The Windtree Therapeutics stock price is 1.92 USD today.
-
Will WINT stock go up or go down?Windtree Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Windtree Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Windtree Therapeutics is overvalued.
Is Windtree Therapeutics Stock a Buy?
-
Windtree Therapeutics share price is 1.92 while WINT 8-day exponential moving average is 2.21, which is a Sell signal.
-
The stock price of WINT is 1.92 while Windtree Therapeutics 20-day EMA is 3.51, which makes it a Sell.
-
Windtree Therapeutics 50-day exponential moving average is 10.64 while WINT share price is 1.92, making it a Sell technically.
-
WINT stock price is 1.92 and Windtree Therapeutics 200-day simple moving average is 259.82, creating a Sell signal.
Fundamental Analysis of Windtree Therapeutics
Is Windtree Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $141.75 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Windtree Therapeutics
Should I short Windtree Therapeutics stock?
-
WINT Moving Average Covergence Divergence (MACD) indicator is -1.78, suggesting Windtree Therapeutics is a Sell
-
Windtree Therapeutics Relative Strength Index (RSI) is 22.01, which suggest Windtree Therapeutics is oversold
-
The Bollinger Bands (25) for Windtree Therapeutics is (2.03 - 6.35), which suggest Windtree Therapeutics is a Sell
-
The Bollinger Bands (100) for Windtree Therapeutics is (4.97 - 30.69), which suggest Windtree Therapeutics is a Sell
* Windtree Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.